메뉴 건너뛰기




Volumn 58, Issue 4, 2013, Pages 1424-1435

Terutroban, a TP-receptor antagonist, reduces portal pressure in cirrhotic rats

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; ALPHA SMOOTH MUSCLE ACTIN; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; CARBON TETRACHLORIDE; COLLAGEN TYPE 1; CYCLIC GMP; ENDOTHELIAL NITRIC OXIDE SYNTHASE; MESSENGER RNA; RHO KINASE; TERUTROBAN; TRANSFORMING GROWTH FACTOR BETA;

EID: 84884979418     PISSN: 02709139     EISSN: 15273350     Source Type: Journal    
DOI: 10.1002/hep.26520     Document Type: Article
Times cited : (40)

References (42)
  • 1
    • 0034053015 scopus 로고    scopus 로고
    • Complications of cirrhosis. I. Portal hypertension
    • Bosch J, Garcia-Pagan JC. Complications of cirrhosis. I. Portal hypertension. J Hepatol 2000;32:141-156.
    • (2000) J Hepatol , vol.32 , pp. 141-156
    • Bosch, J.1    Garcia-Pagan, J.C.2
  • 3
    • 0037221217 scopus 로고    scopus 로고
    • Cyclooxygenase-derived products modulate the increased intrahepatic resistance of cirrhotic rat livers
    • Graupera M, Garcia-Pagan JC, Abraldes JG, Peralta C, Bragulat M, Corominola H, et al. Cyclooxygenase-derived products modulate the increased intrahepatic resistance of cirrhotic rat livers. Hepatology 2003;37:172-181.
    • (2003) Hepatology , vol.37 , pp. 172-181
    • Graupera, M.1    Garcia-Pagan, J.C.2    Abraldes, J.G.3    Peralta, C.4    Bragulat, M.5    Corominola, H.6
  • 5
    • 0036154951 scopus 로고    scopus 로고
    • The paradox of nitric oxide in cirrhosis and portal hypertension: too much, not enough
    • Wiest R, Groszmann RJ. The paradox of nitric oxide in cirrhosis and portal hypertension: too much, not enough. Hepatology 2002;35:478-491.
    • (2002) Hepatology , vol.35 , pp. 478-491
    • Wiest, R.1    Groszmann, R.J.2
  • 6
    • 0345118191 scopus 로고    scopus 로고
    • Deficit in nitric oxide production in cirrhotic rat livers is located in the sinusoidal and postsinusoidal areas
    • Loureiro-Silva MR, Cadelina GW, Groszmann RJ. Deficit in nitric oxide production in cirrhotic rat livers is located in the sinusoidal and postsinusoidal areas. Am J Physiol Gastrointest Liver Physiol 2003;284:G567-G574.
    • (2003) Am J Physiol Gastrointest Liver Physiol , vol.284
    • Loureiro-Silva, M.R.1    Cadelina, G.W.2    Groszmann, R.J.3
  • 9
    • 34447102726 scopus 로고    scopus 로고
    • Enhanced vasoconstrictor prostanoid production by sinusoidal endothelial cells increases portal perfusion pressure in cirrhotic rat livers
    • Gracia-Sancho J, Lavina B, Rodriguez-Vilarrupla A, Garcia-Caldero H, Bosch J, Garcia-Pagan JC. Enhanced vasoconstrictor prostanoid production by sinusoidal endothelial cells increases portal perfusion pressure in cirrhotic rat livers. J Hepatol 2007;47:220-227.
    • (2007) J Hepatol , vol.47 , pp. 220-227
    • Gracia-Sancho, J.1    Lavina, B.2    Rodriguez-Vilarrupla, A.3    Garcia-Caldero, H.4    Bosch, J.5    Garcia-Pagan, J.C.6
  • 12
    • 42649113385 scopus 로고    scopus 로고
    • Thromboxane A2: physiology/pathophysiology, cellular signal transduction and pharmacology
    • Nakahata N. Thromboxane A2: physiology/pathophysiology, cellular signal transduction and pharmacology. Pharmacol Ther 2008;118:18-35.
    • (2008) Pharmacol Ther , vol.118 , pp. 18-35
    • Nakahata, N.1
  • 13
    • 0032474559 scopus 로고    scopus 로고
    • New tetrahydronaphthalene derivatives as combined thromboxane receptor antagonists and thromboxane synthase inhibitors
    • Cimetiere B, Dubuffet T, Landras C, Descombes JJ, Simonet S, Verbeuren TJ, et al. New tetrahydronaphthalene derivatives as combined thromboxane receptor antagonists and thromboxane synthase inhibitors. Bioorg Med Chem Lett 1998;8:1381-1386.
    • (1998) Bioorg Med Chem Lett , vol.8 , pp. 1381-1386
    • Cimetiere, B.1    Dubuffet, T.2    Landras, C.3    Descombes, J.J.4    Simonet, S.5    Verbeuren, T.J.6
  • 14
    • 0037414069 scopus 로고    scopus 로고
    • Improved endothelial function by the thromboxane A2 receptor antagonist S 18886 in patients with coronary artery disease treated with aspirin
    • Belhassen L, Pelle G, Dubois-Rande JL, Adnot S. Improved endothelial function by the thromboxane A2 receptor antagonist S 18886 in patients with coronary artery disease treated with aspirin. J Am Coll Cardiol 2003;41:1198-1204.
    • (2003) J Am Coll Cardiol , vol.41 , pp. 1198-1204
    • Belhassen, L.1    Pelle, G.2    Dubois-Rande, J.L.3    Adnot, S.4
  • 15
    • 77953738863 scopus 로고    scopus 로고
    • Terutroban, a thromboxane/prostaglandin endoperoxide receptor antagonist, increases survival in stroke-prone rats by preventing systemic inflammation and endothelial dysfunction: comparison with aspirin and rosuvastatin
    • Gelosa P, Ballerio R, Banfi C, Nobili E, Gianella A, Pignieri A, et al. Terutroban, a thromboxane/prostaglandin endoperoxide receptor antagonist, increases survival in stroke-prone rats by preventing systemic inflammation and endothelial dysfunction: comparison with aspirin and rosuvastatin. J Pharmacol Exp Ther 2010;334:199-205.
    • (2010) J Pharmacol Exp Ther , vol.334 , pp. 199-205
    • Gelosa, P.1    Ballerio, R.2    Banfi, C.3    Nobili, E.4    Gianella, A.5    Pignieri, A.6
  • 16
  • 17
    • 33644746320 scopus 로고    scopus 로고
    • The thromboxane receptor antagonist S18886 attenuates renal oxidant stress and proteinuria in diabetic apolipoprotein E-deficient mice
    • Xu S, Jiang B, Maitland KA, Bayat H, Gu J, Nadler JL, et al. The thromboxane receptor antagonist S18886 attenuates renal oxidant stress and proteinuria in diabetic apolipoprotein E-deficient mice. Diabetes 2006;55:110-119.
    • (2006) Diabetes , vol.55 , pp. 110-119
    • Xu, S.1    Jiang, B.2    Maitland, K.A.3    Bayat, H.4    Gu, J.5    Nadler, J.L.6
  • 18
    • 67349087745 scopus 로고    scopus 로고
    • Thromboxane prostanoid receptor activation impairs endothelial nitric oxide-dependent vasorelaxations: the role of Rho kinase
    • Liu CQ, Leung FP, Wong SL, Wong WT, Lau CW, Lu L, et al. Thromboxane prostanoid receptor activation impairs endothelial nitric oxide-dependent vasorelaxations: the role of Rho kinase. Biochem Pharmacol 2009;78:374-381.
    • (2009) Biochem Pharmacol , vol.78 , pp. 374-381
    • Liu, C.Q.1    Leung, F.P.2    Wong, S.L.3    Wong, W.T.4    Lau, C.W.5    Lu, L.6
  • 20
    • 84859709385 scopus 로고    scopus 로고
    • PPARalpha activation improves endothelial dysfunction and reduces fibrosis and portal pressure in cirrhotic rats
    • Rodriguez-Vilarrupla A, Lavina B, Garcia-Caldero H, Russo L, Rosado E, Roglans N, et al. PPARalpha activation improves endothelial dysfunction and reduces fibrosis and portal pressure in cirrhotic rats. J Hepatol 2012;56:1033-1039.
    • (2012) J Hepatol , vol.56 , pp. 1033-1039
    • Rodriguez-Vilarrupla, A.1    Lavina, B.2    Garcia-Caldero, H.3    Russo, L.4    Rosado, E.5    Roglans, N.6
  • 21
    • 65449130742 scopus 로고    scopus 로고
    • Beneficial effects of sorafenib on splanchnic, intrahepatic, and portocollateral circulations in portal hypertensive and cirrhotic rats
    • Mejias M, Garcia-Pras E, Tiani C, Miquel R, Bosch J, Fernandez M. Beneficial effects of sorafenib on splanchnic, intrahepatic, and portocollateral circulations in portal hypertensive and cirrhotic rats. Hepatology 2009;49:1245-1256.
    • (2009) Hepatology , vol.49 , pp. 1245-1256
    • Mejias, M.1    Garcia-Pras, E.2    Tiani, C.3    Miquel, R.4    Bosch, J.5    Fernandez, M.6
  • 22
    • 65949110335 scopus 로고    scopus 로고
    • TP receptor antagonism: a new concept in atherothrombosis and stroke prevention
    • Chamorro A. TP receptor antagonism: a new concept in atherothrombosis and stroke prevention. Cerebrovasc Dis 2009;27(Suppl 3):20-27.
    • (2009) Cerebrovasc Dis , vol.27 , Issue.SUPPL 3 , pp. 20-27
    • Chamorro, A.1
  • 23
    • 34047116831 scopus 로고    scopus 로고
    • Renal effects of S18886 (terutroban), a TP receptor antagonist, in an experimental model of type 2 diabetes
    • Sebekova K, Eifert T, Klassen A, Heidland A, Amann K. Renal effects of S18886 (terutroban), a TP receptor antagonist, in an experimental model of type 2 diabetes. Diabetes 2007;56:968-974.
    • (2007) Diabetes , vol.56 , pp. 968-974
    • Sebekova, K.1    Eifert, T.2    Klassen, A.3    Heidland, A.4    Amann, K.5
  • 24
    • 0030776797 scopus 로고    scopus 로고
    • Losartan prevents thromboxane A2/prostanoid (TP) receptor mediated increase in microvascular permeability in the rat
    • Valentin JP, Jover B, Maffre M, Bertolino F, Bessac AM, John GW. Losartan prevents thromboxane A2/prostanoid (TP) receptor mediated increase in microvascular permeability in the rat. Am J Hypertens 1997;10:1058-1063.
    • (1997) Am J Hypertens , vol.10 , pp. 1058-1063
    • Valentin, J.P.1    Jover, B.2    Maffre, M.3    Bertolino, F.4    Bessac, A.M.5    John, G.W.6
  • 25
    • 84872385637 scopus 로고    scopus 로고
    • Recombinant human manganese superoxide dismutase reduces liver fibrosis and portal pressure in CCl4-cirrhotic rats
    • Guillaume M, Rodriguez-Vilarrupla A, Gracia-Sancho J, Rosado E, Mancini A, Bosch J, et al. Recombinant human manganese superoxide dismutase reduces liver fibrosis and portal pressure in CCl4-cirrhotic rats. J Hepatol 2013;58:240-246.
    • (2013) J Hepatol , vol.58 , pp. 240-246
    • Guillaume, M.1    Rodriguez-Vilarrupla, A.2    Gracia-Sancho, J.3    Rosado, E.4    Mancini, A.5    Bosch, J.6
  • 26
    • 0031682956 scopus 로고    scopus 로고
    • Endothelial dysfunction and decreased production of nitric oxide in the intrahepatic microcirculation of cirrhotic rats
    • Gupta TK, Toruner M, Chung MK, Groszmann RJ. Endothelial dysfunction and decreased production of nitric oxide in the intrahepatic microcirculation of cirrhotic rats. Hepatology 1998;28:926-931.
    • (1998) Hepatology , vol.28 , pp. 926-931
    • Gupta, T.K.1    Toruner, M.2    Chung, M.K.3    Groszmann, R.J.4
  • 28
    • 79952697695 scopus 로고    scopus 로고
    • Tempol administration, a superoxide dismutase mimetic, reduces hepatic vascular resistance and portal pressure in cirrhotic rats
    • Garcia-Caldero H, Rodriguez-Vilarrupla A, Gracia-Sancho J, Divi M, Lavina B, Bosch J, et al. Tempol administration, a superoxide dismutase mimetic, reduces hepatic vascular resistance and portal pressure in cirrhotic rats. J Hepatol 2010;54:660-665.
    • (2010) J Hepatol , vol.54 , pp. 660-665
    • Garcia-Caldero, H.1    Rodriguez-Vilarrupla, A.2    Gracia-Sancho, J.3    Divi, M.4    Lavina, B.5    Bosch, J.6
  • 29
    • 40949127068 scopus 로고    scopus 로고
    • Large-conductance calcium-activated potassium channels modulate vascular tone in experimental cirrhosis
    • Rodriguez-Vilarrupla A, Graupera M, Matei V, Bataller R, Abraldes JG, Bosch J, et al. Large-conductance calcium-activated potassium channels modulate vascular tone in experimental cirrhosis. Liver Int 2008;28:566-573.
    • (2008) Liver Int , vol.28 , pp. 566-573
    • Rodriguez-Vilarrupla, A.1    Graupera, M.2    Matei, V.3    Bataller, R.4    Abraldes, J.G.5    Bosch, J.6
  • 31
    • 34347397134 scopus 로고    scopus 로고
    • Kupffer cell activation in normal and fibrotic livers increases portal pressure via thromboxane A(2)
    • Steib CJ, Gerbes AL, Bystron M, op dW, Hartl J, Roggel F, et al. Kupffer cell activation in normal and fibrotic livers increases portal pressure via thromboxane A(2). J Hepatol 2007;47:228-238.
    • (2007) J Hepatol , vol.47 , pp. 228-238
    • Steib, C.J.1    Gerbes, A.L.2    Bystron, M.3    Op, D.W.4    Hartl, J.5    Roggel, F.6
  • 32
    • 33847060977 scopus 로고    scopus 로고
    • Nitroflurbiprofen, a nitric oxide-releasing cyclooxygenase inhibitor, improves cirrhotic portal hypertension in rats
    • Laleman W, Van Landeghem L, Van der Elst I, Zeegers M, Fevery J, Nevens F. Nitroflurbiprofen, a nitric oxide-releasing cyclooxygenase inhibitor, improves cirrhotic portal hypertension in rats. Gastroenterology 2007;132:709-719.
    • (2007) Gastroenterology , vol.132 , pp. 709-719
    • Laleman, W.1    Van Landeghem, L.2    Van der Elst, I.3    Zeegers, M.4    Fevery, J.5    Nevens, F.6
  • 33
    • 0021994982 scopus 로고
    • Effects of prostaglandin inhibition on systemic and hepatic hemodynamics in patients with cirrhosis of the liver
    • Bruix J, Bosch J, Kravetz D, Mastai R, Rodes J. Effects of prostaglandin inhibition on systemic and hepatic hemodynamics in patients with cirrhosis of the liver. Gastroenterology 1985;88:430-435.
    • (1985) Gastroenterology , vol.88 , pp. 430-435
    • Bruix, J.1    Bosch, J.2    Kravetz, D.3    Mastai, R.4    Rodes, J.5
  • 34
    • 0036185248 scopus 로고    scopus 로고
    • Cyclooxygenase-1 derived prostaglandins are involved in the maintenance of renal function in rats with cirrhosis and ascites
    • Lopez-Parra M, Claria J, Planaguma A, Titos E, Masferrer JL, Woerner BM, et al. Cyclooxygenase-1 derived prostaglandins are involved in the maintenance of renal function in rats with cirrhosis and ascites. Br J Pharmacol 2002;135:891-900.
    • (2002) Br J Pharmacol , vol.135 , pp. 891-900
    • Lopez-Parra, M.1    Claria, J.2    Planaguma, A.3    Titos, E.4    Masferrer, J.L.5    Woerner, B.M.6
  • 35
    • 0018389197 scopus 로고
    • Effect of indomethacin and prostaglandin A1 on renal function and plasma renin activity in alcoholic liver disease
    • Boyer TD, Zia P, Reynolds TB. Effect of indomethacin and prostaglandin A1 on renal function and plasma renin activity in alcoholic liver disease. Gastroenterology 1979;77:215-222.
    • (1979) Gastroenterology , vol.77 , pp. 215-222
    • Boyer, T.D.1    Zia, P.2    Reynolds, T.B.3
  • 36
    • 79958770159 scopus 로고    scopus 로고
    • Terutroban versus aspirin in patients with cerebral ischaemic events (PERFORM): a randomised, double-blind, parallel-group trial
    • Bousser MG, Amarenco P, Chamorro A, Fisher M, Ford I, Fox KM, et al. Terutroban versus aspirin in patients with cerebral ischaemic events (PERFORM): a randomised, double-blind, parallel-group trial. Lancet 2011;377:2013-2022.
    • (2011) Lancet , vol.377 , pp. 2013-2022
    • Bousser, M.G.1    Amarenco, P.2    Chamorro, A.3    Fisher, M.4    Ford, I.5    Fox, K.M.6
  • 38
    • 67650539078 scopus 로고    scopus 로고
    • Thromboxane A2 receptor activates a Rho-associated kinase/LKB1/PTEN pathway to attenuate endothelium insulin signaling
    • Song P, Zhang M, Wang S, Xu J, Choi HC, Zou MH. Thromboxane A2 receptor activates a Rho-associated kinase/LKB1/PTEN pathway to attenuate endothelium insulin signaling. J Biol Chem 2009;284:17120-17128.
    • (2009) J Biol Chem , vol.284 , pp. 17120-17128
    • Song, P.1    Zhang, M.2    Wang, S.3    Xu, J.4    Choi, H.C.5    Zou, M.H.6
  • 39
    • 33847054334 scopus 로고    scopus 로고
    • Both Ca2+ -dependent and -independent pathways are involved in rat hepatic stellate cell contraction and intrahepatic hyperresponsiveness to methoxamine
    • Laleman W, Van LL, Severi T, Vander E, I, Zeegers M, Bisschops R, et al. Both Ca2+ -dependent and -independent pathways are involved in rat hepatic stellate cell contraction and intrahepatic hyperresponsiveness to methoxamine. Am J Physiol Gastrointest Liver Physiol 2007;292:G556-G564.
    • (2007) Am J Physiol Gastrointest Liver Physiol , vol.292
    • Laleman, W.1    Van, L.L.2    Severi, T.3    Vander, I.E.4    Zeegers, M.5    Bisschops, R.6
  • 40
    • 33747810129 scopus 로고    scopus 로고
    • Intrahepatic upregulation of RhoA and Rho-kinase signalling contributes to increased hepatic vascular resistance in rats with secondary biliary cirrhosis
    • Zhou Q, Hennenberg M, Trebicka J, Jochem K, Leifeld L, Biecker E, et al. Intrahepatic upregulation of RhoA and Rho-kinase signalling contributes to increased hepatic vascular resistance in rats with secondary biliary cirrhosis. Gut 2006;55:1296-1305.
    • (2006) Gut , vol.55 , pp. 1296-1305
    • Zhou, Q.1    Hennenberg, M.2    Trebicka, J.3    Jochem, K.4    Leifeld, L.5    Biecker, E.6
  • 41
    • 84869222173 scopus 로고    scopus 로고
    • HSC-specific inhibition of Rho-kinase reduces portal pressure in cirrhotic rats without major systemic effects
    • Klein S, Van Beuge MM, Granzow M, Beljaars L, Schierwagen R, Kilic S, et al. HSC-specific inhibition of Rho-kinase reduces portal pressure in cirrhotic rats without major systemic effects. J Hepatol 2012;57:1220-1227
    • (2012) J Hepatol , vol.57 , pp. 1220-1227
    • Klein, S.1    Van Beuge, M.M.2    Granzow, M.3    Beljaars, L.4    Schierwagen, R.5    Kilic, S.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.